Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey

Acta Neurochirurgica

Volumn 156, Issue 12, 2014, Pages 2315-2324

  Stummer, Walter ^a   Rodrigues, Floriano ^b   Schucht, Philippe ^c   Preuss, Matthias ^d   Wiewrodt, Dorothee ^a   Nestler, Ulf ^d   Stein, Marco ^e   Artero, José Manuel Cabezudo ^f   Platania, Nunzio ^g   Skjøth Rasmussen, Jane ^h   Puppa, Alessandro Della ⁱ   Caird, John ^j   Cortnum, Søren ^k   Eljamel, Sam ^l   Ewald, Christian ^m   González García, Laura ⁿ   Martin, Andrew J ^o   Melada, Ante ^p   Peraud, Aurelia ^q   Brentrup, Angela ^a   Santarius, Thomas ^r   Steiner, Hans Herbert ^s   more..

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MEDAC GMBH   (Germany)

^c Neurosurgical Department   (Switzerland)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f HOSPITAL INFANTA CRISTINA   (Spain)

^g UNIVERSITY OF CATANIA   (Italy)

^h University of Copenhagen   (Denmark)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^j BEAUMONT HOSPITAL   (Ireland)

^k AALBORG UNIVERSITY HOSPITAL   (Denmark)

^l UNIVERSITY OF DUNDEE   (United Kingdom)

^m JENA UNIVERSITY HOSPITAL   (Germany)

ⁿ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^o ST GEORGE S HOSPITAL   (United Kingdom)

^p UHC Zagreb ^*  (Croatia)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r ADDENBROOKE S HOSPITAL   (United Kingdom)

^s Nuremberg Southern Hospital   (Germany)

more..

Author keywords

5 ALA; Anaplastic astrocytoma; Ependymoma; Fluorescence guided resection; Glioblastoma; Gliolan; Medulloblastoma; Pediatric brain tumor

Indexed keywords

AMINOLEVULINIC ACID; CONTRAST MEDIUM;

ADOLESCENT; ANISOCORIA; APHASIA; ARTICLE; ASTROCYTOMA; ATAXIA; BRAIN CANCER; BRAIN HISTOLOGY; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CEREBRAL SALT WASTING; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLEX PARTIAL SEIZURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DROWSINESS; DYSLEXIA; EPENDYMOMA; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; FLUORESCENCE; FLUORESCENCE GUIDED RESECTION; FUNCTIONAL NEUROIMAGING; GLIAL FIBRILLARY ASTROCYTOMA; GLIOBLASTOMA; GLIOMA; HEADACHE; HEMIPARESIS; HOARSENESS; HUMAN; HYDROCEPHALUS; HYGROMA; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; MOTOR DYSFUNCTION; NAUSEA; NECK PAIN; NEUROLOGIC DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OLIGODENDROGLIOMA; PEDIATRICS; PERSONALITY DISORDER; PILOCYTIC ASTROCYTOMA; POSTERIOR FOSSA SYNDROME; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOMNOLENCE; VASOSPASM; VISUAL DISORDER; VOMITING; WALKING; WALKING DIFFICULTY; BRAIN NEOPLASMS; CLINICAL TRIAL; EUROPE; EVALUATION STUDY; FLUORESCENCE IMAGING; INFANT; INFORMATION PROCESSING; MULTICENTER STUDY; PRESCHOOL CHILD; PROCEDURES; UTILIZATION;

ADOLESCENT; AMINOLEVULINIC ACID; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DATA COLLECTION; EUROPE; FEMALE; FLUORESCENCE; GLIOMA; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; OPTICAL IMAGING; RETROSPECTIVE STUDIES;

EID: 84922073780     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-014-2234-2     Document Type: Article

References (29)

1. Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Diez-Valle R (2013) Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72(6):915–20, discussion 920–921
2. Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neuro-Oncol 102(1):105–113
3. Haj-Hosseini N, Richter J, Andersson-Engels S, Wardell K (2010) Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. doi:10.1002/lsm.20868
4. Piccirillo SGM, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C (2012) Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer 107(3):462–468
5. Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34(3):314–317
6. Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurgery 71(5):927–35, discussion 935–936
7. Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J (2014) 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir (Wien) 156(2):305–312, discussion 312
8. Schucht P, Murek M, Jilch A, Seidel K, Hewer E, Wiest R, Raabe A, Beck J (2013) Early re-do surgery for glioblastoma is a feasible and safe strategy to achieve complete resection of enhancing tumor. PLoS One. doi:10.1371/journal.pone.0079846
9. Stummer W, Tonn J-C, Goetz C, Ullrich W, Stepp H, Bink A, Pietsch T, Pichlmeier U (2014) 5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. Neurosurgery 74(3):310–9, discussion 319–320
10. Valdes PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, Tosteson TD, Hartov A, Ji S, Erkmen K, Simmons NE, Paulsen KD, Roberts DW (2011) Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115(1):11–17
11. Della Puppa A, Rustemi O, Gioffre G, Troncon I, Lombardi G, Rolma G, Sergi M, Munari M, Cecchin D, Gardiman MP, Scienza R (2014) Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningiomas surgery. J Neurosurg 120(4):840–845
12. Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger H-J, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154(2):223–228, discussion 228
13. Valdes PA, Bekelis K, Harris BT, Wilson BC, Leblond F, Kim A, Simmons NE, Erkmen K, Paulsen KD, Roberts DW (2014) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningiomas: qualitative and quantitative measurements in vivo. Neurosurgery 10(Suppl 1):74–82, discussion 82–83
14. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38(2):265–271
15. Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME (2012) Predictors of survival among pediatric and adult ependymoma cases: a study using surveillance, epidemiology, and end results data from 1973 to 2007. Neuroepidemiology 39(2):116–124
16. Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51(2):245–250
17. Peters O, Gnekow AK, Rating D, Wolff JEA (2004) Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr Blood Cancer 43(3):250–256
18. Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick W, Debus J, Combs SE (2011) Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.12.042
19. Song KS, Phi JH, Cho B-K, Wang K-C, Lee JY, Kim DG, Kim IH, Ahn HS, Park S-H, Kim S-K (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6(2):145–149
20. Stokland T, Liu J-F, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncol 12(12):1257–1268
21. Ruge JR, Liu J (2009) Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor. J Neurosurg Pediatr 4(5):484–486
22. Eicker S, Sarikaya-Seiwert S, Borkhardt A, Gierga K, Turowski B, Heiroth H-J, Steiger H-J, Stummer W (2011) ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. Cent Eur Neurosurg 72(2):101–103
23. Preuss M, Renner C, Krupp W, Christiansen H, Fischer L, Merkenschlager A, Kieß W, Müller W, Manzo N, Meixensberger J, Nestler U (2013) The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 29(8):1263–1267
24. Barbagallo GMV, Certo F, Heiss K, Albanese V (2014) 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature. Br J Neurosurg. doi:10.3109/02688697.2014.913779
25. Beez T, Sarikaya-Seiwert S, Steiger H-J, Hanggi D (2014) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children–a technical report. Acta Neurochir (Wien). doi:10.1007/s00701-014-1997-9
26. Schwake M, Gunes D, Kochling M, Brentrup A, Schroeteler J, Hotfilder M, Fruehwald MC, Stummer W, Ewelt C (2014) Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid. Acta Neurochir (Wien). doi:10.1007/s00701-014-2096-7
27. Ritz R, Scheidle C, Noell S, Roser F, Schenk M, Dietz K, Strauss WSL (2012) In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS One. doi:10.1371/journal.pone.0051974
28. Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 65(6):1070–6, discussion 1076–1077
29. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. doi:10.1016/S1470-2045(06)70665-9